Tiredness · Children with obstructive sleep apnoea (aged 15 years or younger)
It is very uncertain whether oral appliance or functional orthopaedic appliance changes daytime symptom: tiredness (Brouillette questionnaire) compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Daytime symptom: sleepiness (Brouillette questionnaire) · Children with obstructive sleep apnoea (aged 15 years or younger)
It is very uncertain whether oral appliance or functional orthopaedic appliance changes daytime symptom: sleepiness (Brouillette questionnaire) compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Postoperative pain (VAS 0-100) - 1 day · People requiring retreatment of periapical lesions (failed root canal therapy)
Plasma rich in growth factors (PRGF) graft may leads to lower postoperative pain (VAS 0-100) - 1 day compared with no grafting (low certainty).
1 finding from 1 review
Irritability · Children with obstructive sleep apnoea (aged 15 years or younger)
It is very uncertain whether oral appliance or functional orthopaedic appliance changes daytime symptom: irritability (Brouillette questionnaire) compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Daytime symptom: morning headache (Brouillette questionnaire) · Children with obstructive sleep apnoea (aged 15 years or younger)
It is very uncertain whether oral appliance or functional orthopaedic appliance changes daytime symptom: morning headache (Brouillette questionnaire) compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Postoperative pain (VAS 0-100) - 1 day · People requiring retreatment of periapical lesions (failed root canal therapy)
Mineral trioxide aggregate (MTA) root-end filling showed no clear difference in postoperative pain (VAS 0-100) - 1 day compared with gutta-percha smoothing (orthograde GP root filling) (low certainty).
1 finding from 1 review
Chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in chronic lung disease (oxygen use at 28 days in survivors) compared with no supplementation (moderate certainty).
1 finding from 1 review
Death or chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A probably leads to lower death or chronic lung disease (oxygen use at 28 days) compared with no supplementation (moderate certainty).
1 finding from 1 review
Intervention not reported
Early mortality (90 days) · patients with diffuse emphysema
The intervention probably leads to higher early mortality (90 days) (moderate certainty).
1 finding from 1 review
Gavage to full oral feeding (days) · preterm infants
1 finding from 1 review
Start oral feeding to full oral feeding (days) · preterm infants
1 finding from 1 review
Days from birth to full oral breastfeeding · preterm infants
1 finding from 1 review
Length of hospital stay · preterm infants
1 finding from 1 review
Daily weight gain · preterm infants
1 finding from 1 review
Postconceptual age at full oral feeds (days) · preterm infants
1 finding from 1 review
Intervention not reported
Live birth ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
The intervention may leads to lower live birth ‐ Clomiphene citrate 5 days versus clomiphene citrate 10… (low certainty).
1 finding from 1 review
Intervention not reported
Clinical pregnancy ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
The intervention may leads to lower clinical pregnancy ‐ Clomiphene citrate 5 days versus clomiphene… (low certainty).
1 finding from 1 review
Intervention not reported
Multiple pregnancy ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether the intervention changes multiple pregnancy ‐ Clomiphene citrate 5 days versus clomiphene… (very low certainty).
1 finding from 1 review
Overall mortality at 28 days · critically ill participants with ALI and ARDS
INO showed no clear difference in overall mortality at 28 days compared with control group (moderate certainty).
1 finding from 1 review
Ventilator‐free days up to day 28 · critically ill participants with ALI and ARDS
INO showed no clear difference in ventilation‐free days, up to 30 days compared with control group (high certainty).
1 finding from 1 review